Clinical Trial Search
Multiple Myeloma
Click on a link below the country name to see trial details in a specific location
Austria
-
SALZBURG
ML18704
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma Terminated -
WIEN
ML18704
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma Terminated
Canada
-
TORONTO, ON
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed
France
-
BORDEAUX
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
CAEN
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
DIJON
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
LYON
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
MARSEILLE
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
SAINT HERBLAIN
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
TOULOUSE
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
VILLEJUIF
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting
Germany
-
KOELN
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
MANNHEIM
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
MUENCHEN
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
ANSBACH
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
ASCHAFFENBURG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
AUGSBURG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
BERLIN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
BREMEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
DUISBURG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
ERLANGEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
ESSEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
ESSLINGEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
FRANKFURT AM MAIN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
GÖTTINGEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
GREIFSWALD
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
GÜSTROW
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
GÜTERSLOH
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
HALLE
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
HAMBURG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
HAMM
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
HANNOVER
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
HERNE
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
HOF
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
JENA
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
KARLSRUHE
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
KASSEL
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
KOBLENZ
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
KÖLN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
KREFELD
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
LEER
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
LEIPZIG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
LÜBECK
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
LUDWIGSHAFEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
MAGEDBURG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
MINDEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
MOERS
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
MÜLHEIM
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
MÜNCHEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
MÜNSTER
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
NEUMÜNSTER
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
OFFENBACH
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
OFFENBURG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
OLDENBURG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
STUTTGART
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
TÜBINGEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
WEIDEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
WIESBADEN
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
WÜRZBURG
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed -
ZWICKAU
ML18508
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma Completed
Spain
-
BARCELONA
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
MADRID
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
SALAMANCA
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
VALENCIA
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting
U.S.A.
-
SCOTTSDALE, AZ
FRF4998g
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Recruiting -
SEDONA, AZ
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
TUCSON, AZ
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
TUCSON, AZ
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
BURBANK, CA
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
DUARTE, CA
FRF4998g
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Recruiting -
RANCHO CUCAMONGA, CA
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
DENVER, CO
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
DENVER, CO
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
JACKSONVILLE, FL
FRF4998g
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Recruiting -
OCALA, FL
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
SARASOTA, FL
FRF4998g
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Recruiting -
CHICAGO, IL
FRF4998g
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Recruiting -
BOSTON, MA
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
BETHESDA, MD
FRF4998g
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Recruiting -
DETROIT, MI
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
WOODBURY, MN
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
COLUMBIA, MO
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
ST. LOUIS, MO
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
LAS VEGAS, NV
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
NEW YORK, NY
FRF4998g
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Recruiting -
NEW YORK, NY
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
NASHVILLE, TN
FRF4998g
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Recruiting -
NASHVILLE, TN
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
NASHVILLE, TN
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
AMARILLO, TX
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
AUSTIN, TX
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
DALLAS, TX
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
DENTON, TX
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
HOUSTON, TX
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
MCALLEN, TX
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
TYLER, TX
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
SPOKANE, WA
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
YAKIMA, WA
ML28560
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment into Clinical Research Studies of Zelboraf (Vemurafenib) Recruiting -
YAKIMA, WA
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
SCOTTSDALE, AZ
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
ATLANTA, GA
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
CHICAGO, IL
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
BOSTON, MA
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
ANN ARBOR, MI
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
DETROIT, MI
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
HACKENSACK, NJ
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
NEW YORK, NY
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
DALLAS, TX
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
SALT LAKE CITY, UT
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed -
SEATTLE, WA
MFG4809g
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma Completed
United Kingdom
-
ABERDEEN
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
LONDON
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting -
SUTTON
MO28072
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers Recruiting